{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.66 vs. cons $3.60",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Global Skyrizi net revenue",
      "prediction": "BEAT",
      "answer": "pred ~$5.18B vs. cons $5.05B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Worldwide net revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$16.82B vs. cons $16.70B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted diluted EPS guidance, including disclosed acquired-I PR&D and milestones charges",
      "prediction": "BETTER",
      "answer": "guide ~$14.16 vs. cons $14.08 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 worldwide net-revenue outlook",
      "prediction": "BETTER",
      "answer": "guide ~$67.5B vs. cons $67.4B (FY26)",
      "confidence": "LOW"
    },
    {
      "kpi": "FY26 Skyrizi revenue outlook",
      "prediction": "BETTER",
      "answer": "guide ~$21.8B vs. cons $21.6B (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.7,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.8,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A ~$0.06 EPS beat versus $3.60 consensus plus a ~$0.10 FY26 EPS-guide raise versus $14.08 should lift out-period estimates; Skyrizi revenue of ~$5.18B versus $5.05B supports a higher ~$21.8B FY26 outlook versus $21.6B consensus, making the beat more durable than a charge-driven EPS variance.",
  "day5_confidence": "MEDIUM"
}